NorthWest Biotherapeutics Inc (NWBO)

[WideEyed]

Hey Barunuuk,
A conservative comparison for DCVax-L is Keytruda; if we ask ourselves which is more valuable the answer is... DCVax-L, by FAR and AWAY more valuable. If we do an internet search on Keytruda sales we find that 5th year sales were about 27 Billion. Using a conservative multiplier of 10x and number of NWBO shares of 2 billion, we get ($27 Billion x 10x) / 2 billion shares = $135 per share after 5 years. And this is a conservative estimate, so I'd say Yes, your estimate of $100 per share is quite accurate. We haven't even factored in DCVax-Direct either. Cheers!